Article
Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
The Journal of antimicrobial chemotherapy - 1 Oct 2014
Palella Frank J, Armon Carl, Buchacz Kate, Chmiel Joan S, Novak Richard M, D'Aquila Richard T, Brooks John T
Abstract excerpt
BACKGROUND: Identifying factors associated with mortality for HIV-infected patients with persistent viraemia despite antiretroviral (ARV) therapy may inform diagnostic and treatment strategies. METHODS: We analysed data from viraemic triple-ARV-class-experienced HIV Outpatient Study patients seen during 1 January 1999 to 31 December 2012 who, despite treatment that included ARVs from three major drug classes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.